Physician
Murali Davuluri MD Apmc
Murali Davuluri MD Apmc was paid $2.92M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoMURALI DAVULURI MD APMC
HOUMA, LA 70360
HOUMA, LA 70360
33aNPI1043363260assigned 01/19/2007
33bProvider typePediatrics Physician
28Total paid$2.92M
24GClaims109,416
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#44 of 230
Median peer was paid$429K
This provider vs. median6.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,751 | $399K | |
| 2019 | 15,099 | $394K | |
| 2020 | 14,367 | $354K | |
| 2021 | 13,214 | $381K | |
| 2022 | 17,938 | $518K | |
| 2023 | 18,310 | $458K | |
| 2024incomplete | 15,737 | $414K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 24,539 | 20,586 | $1.12M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 5,369 | 4,956 | $364K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8.5% | 8,986 | 8,490 | $247K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.7% | 3,102 | 2,955 | $197K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.7% | 2,777 | 2,664 | $194K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.5% | 2,420 | 2,332 | $160K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.2% | 1,995 | 1,862 | $122K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.8% | 8,355 | 7,964 | $112K |
| 99188 | 2.5% | 5,313 | 4,566 | $73K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.4% | 2,011 | 1,821 | $69K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.3% | 4,394 | 4,118 | $67K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 5,147 | 2,347 | $61K |
44 more codes
| 92551 | 1.8% | 6,981 | $53K | |
| 90473 | <1% | 2,041 | $18K | |
| 90474 | <1% | 1,530 | $12K | |
| 69210 | <1% | 446 | $11K | |
| 99173 | <1% | 7,326 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 837 | $10K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 119 | $8K |
| 99381 | <1% | 29 | $2K | |
| 92283 | <1% | 67 | $2K | |
| 0072A | <1% | 32 | $1K | |
| 0071A | <1% | 31 | $1K | |
| 17110 | <1% | 12 | $913.68 | |
| 85018 | <1% | 341 | $745.86 | |
| 54450 | <1% | 12 | $727.87 | |
| 81002 | <1% | 291 | $654.52 | |
| 87807 | <1% | 61 | $641.90 | |
| 90480 | <1% | 21 | $434.74 | |
| 0001A | <1% | 12 | $433.72 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 25 | $245.78 |
| 92567 | <1% | 15 | $167.43 | |
| 90656 | <1% | 193 | $55.89 | |
| 90671 | <1% | 239 | $0.09 | |
| 90633 | <1% | 813 | $0.03 | |
| 90651 | <1% | 1,168 | $0.02 | |
| 90698 | 0% | 1,748 | $0.00 | |
| 90620 | 0% | 759 | $0.00 | |
| 90680 | 0% | 868 | $0.00 | |
| 90686 | 0% | 2,471 | $0.00 | |
| 90744 | 0% | 472 | $0.00 | |
| 90660 | 0% | 425 | $0.00 | |
| 91307 | 0% | 79 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 23 | $0.00 |
| 90716 | 0% | 16 | $0.00 | |
| 90670 | 0% | 1,292 | $0.00 | |
| 90685 | 0% | 188 | $0.00 | |
| 90672 | 0% | 2,481 | $0.00 | |
| 90734 | 0% | 779 | $0.00 | |
| 90713 | 0% | 67 | $0.00 | |
| 90715 | 0% | 48 | $0.00 | |
| 90700 | 0% | 530 | $0.00 | |
| 90648 | 0% | 27 | $0.00 | |
| 90710 | 0% | 53 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 23 | $0.00 |
| 90707 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVULURI, MURALI (PRESIDENT)
Parent organizationMURALI DAVULURI MD A PROFESSIONAL MEDICAL CORPORATION